Gainers
-
Isle of Capri Casinos (NASDAQ: ISLE) rose 21.2
percent to $20.51 in pre-market trading. Eldorado Resorts, Inc. (NYSE: ERI) and Isle of Capri Casinos, Inc. struck a merger deal through which the former
would buy the latter for $23 a share in cash or 1.638 shares.
-
Avnet, Inc. (NYSE: AVT) shares rose 12.2 percent to
$44.00 in pre-market trading after the company agreed to sell Technology Solutions business to Tech Data Corp (NASDAQ:
TECD) for $2.6 billion.
-
Infoblox Inc (NYSE: BLOX) shares rose 15 percent to
$26.25 in pre-market trading as the company announced its acquisition by Vista Equity Partners for $26.50 per share in cash.
-
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) rose 13.5
percent to $3.95 in pre-market trading after the company disclosed that its Auriclosene has met primary endpoint in Phase 2b
trial.
-
Everbridge, Inc. (NASDAQ: EVBG) rose 11.5 percent
to $17.00 in pre-market trading after surging 27.08 percent on Friday.
-
Fate Therapeutics Inc (NASDAQ: FATE) rose 10.6
percent to $3.23 in pre-market trading after gaining 4.66 percent on Friday.
-
Geron Corporation (NASDAQ: GERN) rose 9 percent
to $2.05 in pre-market trading after dropping 4.57 percent on Friday.
-
Eldorado Resorts Inc (NYSE: ERI) shares rose 8.6
percent to $15.47 in pre-market trading. Eldorado Resorts, Inc. and Isle of Capri Casinos, Inc. (NASDAQ: ISLE) struck a merger deal through which the former would buy the
latter for $23 a share in cash or 1.638 shares.
-
GoPro Inc (NASDAQ: GPRO) shares rose 4.3 percent
to $15.60 in pre-market trading ahead of new product unveiling event.
-
Tech Data Corp (NASDAQ: TECD) rose 3.9 percent to
$72.05 in the pre-market trading as the company reached a deal with Avnet, Inc. (NYSE: AVT) enabling it to buy the latter's Technology Solutions business. The
transaction comprises cash component of $2.4 billion and 2.785 million shares of Tech Data resulting in a total value of about
$2.6 billion.
-
CoLucid Pharmaceuticals Inc (NASDAQ: CLCD) rose
3.8 percent to $29.19 in pre-market trading after the company issued an interim update on its Phase 3 GLADIATOR study.
-
General Motors Company (NYSE: GM) rose 2.7 percent to
$31.80 in pre-market trading. Morgan Stanley upgraded General Motors from Equal-weight to Overweight and raised the price
target from $29.00 to $37.00.
-
Radius Health Inc (NASDAQ: RDUS) rose 2.3 percent
to $56.39 in the pre-market trading session after the company reported the publication of additional positive results from the
Phase 3 ACTIVE trial of Abaloparatide-SC in the JBMR.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
-
Vical Incorporated (NASDAQ: VICL) fell 18.7
percent to $3.14 in pre-market trading after the company disclosed that its Phase 2 trial did not meet primary endpoint.
-
Community Health Systems (NYSE: CYH) shares fell 3.2
percent to $11.90 in pre-market trading. Community Health confirmed that it is in preliminary discussions with potential
acquirers.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.